Home / Research Library / Global prevalence of sarcopenia and severe sarcope...
🧬 Medicine & Biology OpenAlex

Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis

📅 November 23, 2021 👤 Fanny Petermann‐Rocha, Viktoria Balntzi, Stuart R. Gray et al. 📖 Journal of Cachexia Sarcopenia and Muscle 📊 1,397 citations

🤖 Plain-English Summary

BACKGROUND: Sarcopenia is defined as the loss of muscle mass and strength. CONCLUSIONS: The prevalence of sarcopenia and severe sarcopenia varied considerably according to the classification and cut-off point used.

🔑 Key Findings

  • Despite the seriousness of this disease, a single diagnostic criterion has not yet been established.
  • Few studies have reported the prevalence of sarcopenia globally, and there is a high level of heterogeneity between studies, stemmed from the diagnostic criteria of sarcopenia and the target population.
  • The aims of this systematic review and meta-analysis were (i) to identify and summarize the diagnostic criteria used to define sarcopenia and severe sarcopenia and (ii) to estimate the global and region-specific prevalence of sarcopenia and severe sarcopenia by sociodemographic factors.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Nov 23, 2021
Journal Journal of Cachexia Sarcopenia and Muscle
Authors Fanny Petermann‐Rocha, Viktoria Balntzi, Stuart R. Gray, José Lara, Frederick K. Ho
DOI 10.1002/jcsm.12783
Citations 1,397
Source OpenAlex

More 🧬 Medicine & Biology Research